We’re building on a rich legacy in oncology. With a strong pipeline and renewed commitment to advancing transformative therapies, we aim to improve outcomes and impact the lives of people living with many different types of cancer. Our oncology strategy focuses on high-quality assets across skin, blood, breast, and lung cancers, and centers on four anchor treatments that we believe have the potential to transform patient care.
Inspired by patients worldwide
Breast cancer (Japan)
Multiple myeloma (US)
Cutaneous squamous cell carcinoma, US
Research & Development
We’re investing substantially in the next generation of cancer medicines.
When Cancer Grows Old
This multiyear initiative is intended to address the challenges of cancer and aging.